http://orcid.org/0000-0002-2985-5059
About the Authors
- Silvia-E. Glont
-
Contributed equally to this work with: Silvia-E. Glont, Evangelia K. Papachristou
Roles Conceptualization, Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, United Kingdom
- Evangelia K. Papachristou
-
Contributed equally to this work with: Silvia-E. Glont, Evangelia K. Papachristou
Roles Conceptualization, Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, United Kingdom
- Ashley Sawle
-
Roles Data curation, Formal analysis, Visualization, Writing – review & editing
Affiliation Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, United Kingdom
- Kelly A. Holmes
-
Roles Investigation, Writing – review & editing
Affiliation Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, United Kingdom
- Jason S. Carroll
-
Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review & editing
* E-mail: Rasmus.Siersbaek@cruk.cam.ac.uk (RS); Jason.Carroll@cruk.cam.ac.uk (JC)
Affiliation Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, United Kingdom
- Rasmus Siersbaek
-
Roles Conceptualization, Investigation, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing
* E-mail: Rasmus.Siersbaek@cruk.cam.ac.uk (RS); Jason.Carroll@cruk.cam.ac.uk (JC)
Affiliation Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, United Kingdom
Competing Interests
Jason Carroll is founder and CSO of Azeria Therapeutics. None of the work in this manuscript is related to the work in Azeria Therapeutics. The authors declare no additional competing interests and the declared funding does not alter our adherence to PLOS ONE policies on sharing data and materials.